Suchergebnisse - "Hundsberger, Thomas"
-
1
First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland
ISSN: 1718-7729, 1198-0052, 1718-7729Veröffentlicht: Switzerland MDPI 26.01.2025Veröffentlicht in Current oncology (Toronto) (26.01.2025)“… Belzutifan is a new HIF-α inhibitor mainly used in two different indications: von Hippel–Lindau syndrome-associated renal cell carcinoma, haemangioblastomas …”
Volltext
Journal Article -
2
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
ISSN: 1471-2407, 1471-2407Veröffentlicht: London BioMed Central 15.01.2024Veröffentlicht in BMC cancer (15.01.2024)“… Background Glioblastoma is the most common and most aggressive malignant primary brain tumor in adults. Glioblastoma cells synthesize and secrete large …”
Volltext
Journal Article -
3
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
ISSN: 1470-2045, 1474-5488, 1474-5488Veröffentlicht: England Elsevier Ltd 01.11.2010Veröffentlicht in The lancet oncology (01.11.2010)“… High-dose methotrexate is the standard of care for patients with newly diagnosed primary CNS lymphoma. The role of whole brain radiotherapy is controversial …”
Volltext
Journal Article -
4
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma
ISSN: 1526-632X, 1526-632XVeröffentlicht: United States 24.03.2015Veröffentlicht in Neurology (24.03.2015)“… This is the final report of a phase III randomized study to evaluate whole-brain radiotherapy (WBRT) in primary therapy of primary CNS lymphoma (PCNSL) after a …”
Weitere Angaben
Journal Article -
5
Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes—the Pompe disease burden scale
ISSN: 0340-5354, 1432-1459, 1432-1459Veröffentlicht: Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2019Veröffentlicht in Journal of neurology (01.08.2019)“… Pompe disease is a rare autosomal-recessive disorder characterised by limb-girdle myopathy and respiratory weakness in the late-onset form (LOPD). Various …”
Volltext
Journal Article -
6
Postoperative radiotherapy for meningiomas – a decision-making analysis
ISSN: 1471-2407, 1471-2407Veröffentlicht: London BioMed Central 04.05.2022Veröffentlicht in BMC cancer (04.05.2022)“… Background The management of meningiomas is challenging, and the role of postoperative radiotherapy is not standardized. Methods Radiation oncology experts in …”
Volltext
Journal Article -
7
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
ISSN: 1424-3997, 1424-3997Veröffentlicht: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 18.06.2020Veröffentlicht in Swiss medical weekly (18.06.2020)“… Gliomas are intrinsic brain tumours, which are classified by the World Health Organization (WHO) into different grades of malignancy, with glioblastoma being …”
Volltext
Journal Article -
8
Laser Interstitial Thermal Therapy for Radionecrosis
ISSN: 1558-1349, 1558-1349Veröffentlicht: United States 01.04.2023Veröffentlicht in Neurosurgery clinics of North America (01.04.2023)“… Radiotherapy is widely used for brain tumors but can cause radiation necrosis (RN). Laser interstitial thermal therapy (LITT) is a relatively new therapeutic …”
Weitere Angaben
Journal Article -
9
Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis
ISSN: 1471-2288, 1471-2288Veröffentlicht: London BioMed Central 16.08.2017Veröffentlicht in BMC medical research methodology (16.08.2017)“… Background The objective consensus methodology has recently been applied in consensus finding in several studies on medical decision-making among clinical …”
Volltext
Journal Article -
10
Real-world evidence for Pompe disease remains fragmented. Comment on “A rare partnership: patient community and industry collaboration to shape the impact of real-world evidence on the rare disease ecosystem” by Klein et al
ISSN: 1750-1172, 1750-1172Veröffentlicht: London BioMed Central 14.02.2025Veröffentlicht in Orphanet journal of rare diseases (14.02.2025)“… In a recent publication by Klein et al., the need for real-world data on rare diseases is highlighted. We strongly support this need, and the collaboration …”
Volltext
Journal Article -
11
Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high‐resolution ultrasound study
ISSN: 2162-3279, 2162-3279Veröffentlicht: United States John Wiley & Sons, Inc 01.04.2023Veröffentlicht in Brain and behavior (01.04.2023)“… Aim To investigate the maturation of the peripheral nervous system by analyzing the cross‐sectional area of the sciatic nerve during the first 2 years of life …”
Volltext
Journal Article -
12
Natural ghrelin in advanced cancer patients with cachexia, a case series
ISSN: 2190-5991, 2190-6009, 2190-6009Veröffentlicht: Germany John Wiley & Sons, Inc 01.04.2021Veröffentlicht in Journal of cachexia, sarcopenia and muscle (01.04.2021)“… Background Natural ghrelin, a peptide growth hormone secretagogue, has a therapeutic potential in cachexia. We designed a dose‐finding trial of subcutaneous …”
Volltext
Journal Article -
13
Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment
ISSN: 1869-4101, 1869-4101Veröffentlicht: Vienna Springer Vienna 09.06.2024Veröffentlicht in Insights into imaging (09.06.2024)“… Purpose To systematically analyse the time course of vessel wall enhancement and associated stenosis in patients with primary angiitis of the central nervous …”
Volltext
Journal Article -
14
Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
ISSN: 1424-3997, 1424-3997Veröffentlicht: Switzerland SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 02.12.2019Veröffentlicht in Swiss medical weekly (02.12.2019)“… AIMS Recurrent glioblastoma (GBM) is a disease with poor prognosis. Although several therapeutic approaches such as chemotherapy, irradiation or surgery have …”
Volltext
Journal Article -
15
Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high‐resolution ultrasound imaging
ISSN: 2162-3279, 2162-3279Veröffentlicht: Los Angeles John Wiley & Sons, Inc 01.08.2022Veröffentlicht in Brain and behavior (01.08.2022)“… Aim To analyze the increase in diameter of the nerve roots C5 and C6 in early childhood. Methods The nerve roots of 56 children aged 0 days to 10 years (47 …”
Volltext
Journal Article -
16
Fitness-to-drive for glioblastoma patients
ISSN: 1424-3997Veröffentlicht: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 16.05.2021Veröffentlicht in Swiss medical weekly (16.05.2021)“… OBJECTIVE The management of brain tumour patients who would like to resume driving is complex, and needs multidisciplinary input and a consensus among treating …”
Volltext
Journal Article -
17
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03
ISSN: 1527-7755, 1527-7755Veröffentlicht: United States 20.09.2006Veröffentlicht in Journal of clinical oncology (20.09.2006)“… To evaluate toxicity and efficacy of the combination of lomustine, temozolomide (TMZ) and involved-field radiotherapy in patients with newly diagnosed …”
Weitere Angaben
Journal Article -
18
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma
ISSN: 2666-3791, 2666-3791Veröffentlicht: United States Elsevier Inc 17.06.2025Veröffentlicht in Cell reports. Medicine (17.06.2025)“… Lisavanbulin is a prodrug of the microtubule-targeting agent avanbulin. Both avanbulin and lisavanbulin have demonstrated significant antitumor activity in …”
Volltext
Journal Article -
19
Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM)
ISSN: 1424-3997, 1424-3997Veröffentlicht: Switzerland 10.05.2021Veröffentlicht in Swiss medical weekly (10.05.2021)“… OBJECTIVE The management of brain tumour patients who would like to resume driving is complex, and needs multidisciplinary input and a consensus among treating …”
Volltext
Journal Article -
20
Hot Topics on COVID-19 and Its Possible Association with Guillain-Barré Syndrome
ISSN: 2514-183X, 2514-183XVeröffentlicht: MDPI AG 01.03.2022Veröffentlicht in Clinical and translational neuroscience (01.03.2022)“… As the COVID-19 pandemic progresses, reports of neurological manifestations are increasing. However, despite a high number of case reports and case series on …”
Volltext
Journal Article